Beta-adrenergic receptors and mechanisms in asthma: The new long-acting beta-agonists

Robert G. Townley

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The objective is to review β-adrenergic receptors and mechanisms in the immediate and late bronchial reaction in asthma and the new long-acting β-agonist. This will be discussed in light of the controversy of the potential adverse effect of regular use of long-acting β-agonists. We studied the effect of for-moterol on the late asthmatic response (LAR) and airway inflammation in guinea-pigs. Formoterol suppressed the LAR, antigen-induced airway inflammation and hyperresponsiveness, although isoproterenol failed to inhibit these parameters. β-Adrenergic hyporesponsiveness, and cholinergic and α-adrenergic hyperresponsiveness have been implicated in the pathogenesis of asthma. A decrease in β-adrenoreceptor function can result either from exogenously administered β-agonist or from exposure to allergens resulting in a late bronchial reaction. There is increasing evidence that eosinophils, macrophages, and lymphocytes which are of primary importance in the late bronchial reaction are also modulated by β2-adrenoreceptors. In functional studies of guinea-pig or human isolated trachea and lung parenchyma, PAF and certain cytokines significantly reduced the potency of isoproterenol to reverse methacholine-or histamine-induced contraction. The effect of glucocorticoids on pulmonary β-adrenergic receptors and responses suggests an important role for glucocorticoids to increase β-adrenergic receptors and responsiveness.

Original languageEnglish (US)
Pages (from-to)13-22
Number of pages10
JournalAllergology International
Volume45
Issue number1
DOIs
StatePublished - 1996

Fingerprint

Receptors, Adrenergic, beta
Adrenergic Receptors
Asthma
Isoproterenol
Adrenergic Agents
Glucocorticoids
Guinea Pigs
Inflammation
Lung
Methacholine Chloride
Trachea
Eosinophils
Allergens
Cholinergic Agents
Histamine
Macrophages
Lymphocytes
Cytokines
Antigens

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy

Cite this

Beta-adrenergic receptors and mechanisms in asthma : The new long-acting beta-agonists. / Townley, Robert G.

In: Allergology International, Vol. 45, No. 1, 1996, p. 13-22.

Research output: Contribution to journalArticle

@article{ca5246b0b1bf49e8b4d83f424ada3845,
title = "Beta-adrenergic receptors and mechanisms in asthma: The new long-acting beta-agonists",
abstract = "The objective is to review β-adrenergic receptors and mechanisms in the immediate and late bronchial reaction in asthma and the new long-acting β-agonist. This will be discussed in light of the controversy of the potential adverse effect of regular use of long-acting β-agonists. We studied the effect of for-moterol on the late asthmatic response (LAR) and airway inflammation in guinea-pigs. Formoterol suppressed the LAR, antigen-induced airway inflammation and hyperresponsiveness, although isoproterenol failed to inhibit these parameters. β-Adrenergic hyporesponsiveness, and cholinergic and α-adrenergic hyperresponsiveness have been implicated in the pathogenesis of asthma. A decrease in β-adrenoreceptor function can result either from exogenously administered β-agonist or from exposure to allergens resulting in a late bronchial reaction. There is increasing evidence that eosinophils, macrophages, and lymphocytes which are of primary importance in the late bronchial reaction are also modulated by β2-adrenoreceptors. In functional studies of guinea-pig or human isolated trachea and lung parenchyma, PAF and certain cytokines significantly reduced the potency of isoproterenol to reverse methacholine-or histamine-induced contraction. The effect of glucocorticoids on pulmonary β-adrenergic receptors and responses suggests an important role for glucocorticoids to increase β-adrenergic receptors and responsiveness.",
author = "Townley, {Robert G.}",
year = "1996",
doi = "10.2332/allergolint.45.13",
language = "English (US)",
volume = "45",
pages = "13--22",
journal = "Allergology International",
issn = "1323-8930",
publisher = "Japanese Society of Allergology",
number = "1",

}

TY - JOUR

T1 - Beta-adrenergic receptors and mechanisms in asthma

T2 - The new long-acting beta-agonists

AU - Townley, Robert G.

PY - 1996

Y1 - 1996

N2 - The objective is to review β-adrenergic receptors and mechanisms in the immediate and late bronchial reaction in asthma and the new long-acting β-agonist. This will be discussed in light of the controversy of the potential adverse effect of regular use of long-acting β-agonists. We studied the effect of for-moterol on the late asthmatic response (LAR) and airway inflammation in guinea-pigs. Formoterol suppressed the LAR, antigen-induced airway inflammation and hyperresponsiveness, although isoproterenol failed to inhibit these parameters. β-Adrenergic hyporesponsiveness, and cholinergic and α-adrenergic hyperresponsiveness have been implicated in the pathogenesis of asthma. A decrease in β-adrenoreceptor function can result either from exogenously administered β-agonist or from exposure to allergens resulting in a late bronchial reaction. There is increasing evidence that eosinophils, macrophages, and lymphocytes which are of primary importance in the late bronchial reaction are also modulated by β2-adrenoreceptors. In functional studies of guinea-pig or human isolated trachea and lung parenchyma, PAF and certain cytokines significantly reduced the potency of isoproterenol to reverse methacholine-or histamine-induced contraction. The effect of glucocorticoids on pulmonary β-adrenergic receptors and responses suggests an important role for glucocorticoids to increase β-adrenergic receptors and responsiveness.

AB - The objective is to review β-adrenergic receptors and mechanisms in the immediate and late bronchial reaction in asthma and the new long-acting β-agonist. This will be discussed in light of the controversy of the potential adverse effect of regular use of long-acting β-agonists. We studied the effect of for-moterol on the late asthmatic response (LAR) and airway inflammation in guinea-pigs. Formoterol suppressed the LAR, antigen-induced airway inflammation and hyperresponsiveness, although isoproterenol failed to inhibit these parameters. β-Adrenergic hyporesponsiveness, and cholinergic and α-adrenergic hyperresponsiveness have been implicated in the pathogenesis of asthma. A decrease in β-adrenoreceptor function can result either from exogenously administered β-agonist or from exposure to allergens resulting in a late bronchial reaction. There is increasing evidence that eosinophils, macrophages, and lymphocytes which are of primary importance in the late bronchial reaction are also modulated by β2-adrenoreceptors. In functional studies of guinea-pig or human isolated trachea and lung parenchyma, PAF and certain cytokines significantly reduced the potency of isoproterenol to reverse methacholine-or histamine-induced contraction. The effect of glucocorticoids on pulmonary β-adrenergic receptors and responses suggests an important role for glucocorticoids to increase β-adrenergic receptors and responsiveness.

UR - http://www.scopus.com/inward/record.url?scp=85010154170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010154170&partnerID=8YFLogxK

U2 - 10.2332/allergolint.45.13

DO - 10.2332/allergolint.45.13

M3 - Article

AN - SCOPUS:85010154170

VL - 45

SP - 13

EP - 22

JO - Allergology International

JF - Allergology International

SN - 1323-8930

IS - 1

ER -